| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Parabilis Medicines, Inc. Common Stock (PBLS) has 5 insiders with recent SEC Form 4 filings, including 9 buys and 0 sells. PBLS is classified in the Biotechnology industry within the Healthcare sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 26.53M | $925.89M | +244.6K | |
| 10% | 1.03M | $35.84M | - | |
| 10% | 533.2K | $18.61M | - | |
| Dir | 12.5K | $436.3K | - | |
| Dir | 5.5K | $193.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 22, 2026 | Ra Capital Management, L.P.52 | Director, 10% Owner | Buy | 244,593 | $28.29 | $6,919,551.27 | +0.2% | |
| Jun 11, 2026 | Sebulsky Alan | Director | Buy | 12,500 | $20.00 | $250,000.00 | New | |
| Jun 11, 2026 | Levy Guy | 10% Owner | Buy | 500,000 | $20.00 | $10,000,000.00 | +42.4% |